Advertisement

Topics

"Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma" Drugs and Medication Database: Page 3

16:57 EDT 23rd March 2019 | BioPortfolio

Here are the most relevant "Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma" Drugs and Medications that we have found in our database.

More Information about "Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma" on BioPortfolio

We have published hundreds of Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma news stories on BioPortfolio along with dozens of Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma Clinical Trials and PubMed Articles about Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma Companies in our database. You can also find out about relevant Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma Drugs and Medications on this site too.

Showing "Monoclonal Antibody Therapy Vaccine Therapy Treating Patients With" Drugs and Medications 51–75 of 93

Possibly Relevant

Libtayo [regeneron pharmaceuticals, inc.]

These highlights do not include all the information needed to use LIBTAYO safely and effectively. See full prescribing information for LIBTAYO. LIBTAYO (cemiplimab-rwlc) injection, for intravenous useInitial U.S. Approval: 09/2018

Gazyva [genentech, inc.]

These highlights do not include all the information needed to use GAZYVA safely and effectively. See full prescribing information for GAZYVA. GAZYVA (obinutuzumab) injection, for intravenous use Initial U.S. Approval: 2013

Flumadine [caraco pharma, inc.]

NA

Soliris [alexion pharmaceuticals inc.]

These highlights do not include all the information needed to use SOLIRIS safely and effectively. See full prescribing information for SOLIRIS. SOLIRIS (eculizumab) injection, for intravenous use Initial U.S. Approval: 2007

Rimantadine hydrochloride [carilion materials management]

RIMANTADINE HYDROCHLORIDE TABLETS, 100 MG

Cosentyx [novartis pharmaceuticals corporation]

These highlights do not include all the information needed to use COSENTYX safely and effectively. See full prescribing information for COSENTYX. COSENTYX (secukinumab) injection, for subcutaneous use COSENTYX (secukinumab) for injection, for subcutaneous

Simponi [janssen biotech, inc.]

These highlights do not include all the information needed to use SIMPONI safely and effectively. See full prescribing information for SIMPONI. SIMPONI (golimumab) injection, for subcutaneous useInitial U.S. Approval: 2009

Rimantadine hydrochloride [bryant ranch prepack]

RIMANTADINE HYDROCHLORIDE TABLETS, 100 MG

Rimantadine hydrochloride [stat rx usa llc]

RIMANTADINE HYDROCHLORIDE TABLETS, 100 MG

Rimantadine hydrochloride [h.j. harkins company, inc.]

RIMANTADINE HYDROCHLORIDE TABLETS, 100 MG

Rimantadine hydrochloride [impax generics]

RIMANTADINE HYDROCHLORIDE TABLETS, 100 MG

Romidepsin [pfizer laboratories div pfizer inc]

These highlights do not include all the information needed to use ROMIDEPSIN safely and effectively.  See full prescribing information for ROMIDEPSIN. ROMIDEPSIN for injection, for intravenous use Initial U.S. Approval:  2009

Romidepsin [teva parenteral medicines, inc.]

These highlights do not include all the information needed to use ROMIDEPSIN safely and effectively.See full prescribing information for ROMIDEPSIN. ROMIDEPSIN for Injection, for intravenous useInitial U.S. Approval: 2009

Nabi-hb [biotest pharmaceuticals corporation]

Hepatitis B Immune Globulin (Human) Nabi-HB Solvent Detergent Treated and Filtered

Cerezyme [genzyme corporation]

NA

Unituxin [united therapeutics corp.]

These highlights do not include all the information needed to use UNITUXIN safely and effectively. See Full Prescribing Information for UNITUXIN. UNITUXIN (dinutuximab) injection, for intravenous use Initial U.S. Approval: 2015

Babybig [california department of public health]

These highlights do not include all the information needed to use BabyBIG, [Botulism Immune Globulin Intravenous (Human)], safely and effectively. See full prescribing information for BabyBIG. BabyBIG [Botulism Immune Globulin Intravenous (Human) (BIG-IV)

Byetta [physicians total care, inc.]

These highlights do not include all the information needed to use BYETTA safely and effectively. See full prescribing information for BYETTA. BYETTA (exenatide) Injection Initial U.S. Approval: 2005

Cimzia [ucb, inc.]

These highlights do not include all the information needed to use CIMZIA® safely and effectively. See full prescribing information for CIMZIA. CIMZIA (certolizumab pegol) for injection, for subcutaneous use CIMZIA (certolizumab pegol) injection, for subc

Indiclor [medi-physics inc.]

INDICLOR™

Acyclovir [northstar rx llc]

Acyclovir Ointment USP, 5%

Acyclovir [tolmar inc.]

Acyclovir Ointment USP, 5% Rx only

Acyclovir [glenmark pharmaceuticals inc., usa]

Acyclovir Ointment USP, 5%

Acyclovir [torrent pharmaceuticals limited]

ACYCLOVIR OINTMENT USP (acyclovir) 5%

Acyclovir [taro pharmaceuticals u.s.a., inc.]

Acyclovir Ointment USP, 5%



Advertisement
Quick Search
Advertisement
Advertisement